The price of Sunshine Biopharma Inc (NASDAQ: SBFM) closed at $0.05 in the last session, down -10.83% from day before closing price of $0.06. In other words, the price has decreased by -$0.0065 from its previous closing price. On the day, 4642345 shares were traded.
Ratios:
We take a closer look at SBFM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.11 and its Current Ratio is at 5.00. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Slilaty Steve N. bought 100,000 shares for $0.10 per share. The transaction valued at 10,000 led to the insider holds 130,000 shares of the business.
Slilaty Steve N. bought 20,000 shares of SBFM for $2,000 on Feb 08 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $0.10 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBFM now has a Market Capitalization of 3.27M and an Enterprise Value of -14.90M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 0.06. Its current Enterprise Value per Revenue stands at -0.73 whereas that against EBITDA is 0.57.
Stock Price History:
Over the past 52 weeks, SBFM has reached a high of $1.40, while it has fallen to a 52-week low of $0.04. The 50-Day Moving Average of the stock is 0.1538, while the 200-Day Moving Average is calculated to be 0.3308.
Shares Statistics:
According to the various share statistics, SBFM traded on average about 15.26M shares per day over the past 3-months and 76.87M shares per day over the past 10 days. A total of 99.45M shares are outstanding, with a floating share count of 91.94M. Insiders hold about 7.55% of the company’s shares, while institutions hold 11.83% stake in the company. Shares short for SBFM as of Feb 29, 2024 were 445.3k with a Short Ratio of 0.03, compared to 102.64k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.82% and a Short% of Float of 0.88%.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.16 and -$0.16 for the fiscal current year, implying an average EPS of -$0.16. EPS for the following year is $0.09, with 1 analysts recommending between $0.09 and $0.09.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $44.4M in the next fiscal year. The high estimate is $44.4M and the low estimate is $44.4M. The average revenue growth estimate for next year is up 97.20% from the average revenue estimate for this year.
